Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05369169 · ClinicalTrials.gov registry record · NA
Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05369169 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 100 participants.
The verdict
NCT05369169, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Conscious attempts to regulate alcohol use are often undermined by automatic attention and arousal processes activated by alcohol cues, as well as by diminished ability to inhibit in-the-moment behaviors. The current study will examine whether a brief behavioral intervention of slow breathing paced at a resonance frequency of the cardiovascular system can interrupt automatic alcohol cue reactivity and enhance cognitive control in binge drinkers. Results from the proposed study may provide new prevention and intervention targets to interrupt unhealthy drinking behaviors.
Interventions
- BEHAVIORAL Resonance breathing
- BEHAVIORAL Low demand cognitive task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05369169
The ClinicalTrials.gov registry entry for NCT05369169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Resonance breathing is the first listed.
NCT05369169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05369169 about?
NCT05369169 is a clinical study titled "Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control". Conscious attempts to regulate alcohol use are often undermined by automatic attention and arousal processes activated by alcohol cues, as well as by diminished ability to inhibit in-the-moment behaviors. The current study will examine whether a brief behavioral intervention of slow breathing paced ...
What is the current status of trial NCT05369169?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2022-07-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05369169?
The interventions under investigation include: Resonance breathing (BEHAVIORAL), Low demand cognitive task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05369169?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.